• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION JETSTREAM XC; CATHETER, PERIPHERAL, ATHERECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION JETSTREAM XC; CATHETER, PERIPHERAL, ATHERECTOMY Back to Search Results
Model Number 45007
Device Problems Display or Visual Feedback Problem (1184); Difficult to Remove (1528)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/31/2022
Event Type  malfunction  
Event Description
It was reported that the catheter was difficult to remove.A 2.1mm jetstream xc catheter was selected for use in an atherectomy procedure.The target lesion was located in the leg and was moderately calcified.At the completion of the jetstream therapy, a bubl error occurred.The technician attempted to remove the catheter over the guidewire, however, it was extremely difficult to remove.The catheter was ultimately able to be removed from the guidewire and patient.Angioplasty was performed to complete the procedure.There were no patient complications.
 
Manufacturer Narrative
Device eval by mfr: the device was visually and microscopically examined for any damage.Visual examination revealed multiple minor buckling along the sheath.The device showed damage to the infusion sheath 14.5cm from the strain relief.Functional testing was performed and during testing the damaged section of the sheath would bulge.Testing was stopped to prevent potentially bursting the sheath.Inspection of the remainder of the device, apart from the observed damage, revealed no other damage or irregularities.
 
Event Description
It was reported that the catheter was difficult to remove.A 2.1mm jetstream xc catheter was selected for use in an atherectomy procedure.The target lesion was located in the leg and was moderately calcified.At the completion of the jetstream therapy, a bubl error occurred.The technician attempted to remove the catheter over the guidewire, however, it was extremely difficult to remove.The catheter was ultimately able to be removed from the guidewire and patient.Angioplasty was performed to complete the procedure.There were no patient complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JETSTREAM XC
Type of Device
CATHETER, PERIPHERAL, ATHERECTOMY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
model farm road
cork
EI  
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key15491205
MDR Text Key301574664
Report Number2124215-2022-36980
Device Sequence Number1
Product Code MCW
UDI-Device Identifier08714729889892
UDI-Public08714729889892
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K133023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/06/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/27/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/22/2024
Device Model Number45007
Device Catalogue Number45007
Device Lot Number0029268015
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/05/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/22/2022
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-